IDXX Idexx Laboratories Inc

Price (delayed)

$693.74

Market cap

$59.16B

P/E Ratio

87.82

Dividend/share

N/A

EPS

$7.9

Enterprise value

$59.79B

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
The company's EPS has surged by 55% YoY and by 16% QoQ
The company's net income has surged by 54% YoY and by 16% QoQ
The quick ratio has soared by 162% YoY but it has decreased by 4.1% QoQ
IDXX's price to earnings (P/E) is 57% higher than its 5-year quarterly average of 56.1 and 33% higher than its last 4 quarters average of 66.0

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
85.28M
Market cap
$59.16B
Enterprise value
$59.79B
Valuations
Price to earnings (P/E)
87.82
Price to book (P/B)
84.34
Price to sales (P/S)
20.76
EV/EBIT
74.93
EV/EBITDA
66.75
EV/Sales
20.92
Earnings
Revenue
$2.86B
EBIT
$797.96M
EBITDA
$895.81M
Free cash flow
$667.16M
Per share
EPS
$7.9
Free cash flow per share
$7.8
Book value per share
$8.23
Revenue per share
$33.42
TBVPS
$23.74
Balance sheet
Total assets
$2.33B
Total liabilities
$1.62B
Debt
$981.91M
Equity
$702.7M
Working capital
$477.14M
Liquidity
Debt to equity
1.4
Current ratio
1.77
Quick ratio
1.18
Net debt/EBITDA
0.7
Margins
EBITDA margin
31.3%
Gross margin
58.9%
Net margin
23.6%
Operating margin
27.9%
Efficiency
Return on assets
31.2%
Return on equity
131.7%
Return on invested capital
38.9%
Return on capital employed
46.8%
Return on sales
27.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
1.57%
1 week
3.89%
1 month
12.64%
1 year
92.26%
YTD
38.78%
QTD
9.85%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$2.86B
Gross profit
$1.68B
Operating income
$797.82M
Net income
$674.21M
Gross margin
58.9%
Net margin
23.6%
The company's net income has surged by 54% YoY and by 16% QoQ
IDXX's operating income is up by 41% YoY and by 15% from the previous quarter
The net margin has grown by 33% YoY and by 10% from the previous quarter
The gross profit has increased by 21% YoY and by 7% QoQ

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
87.82
P/B
84.34
P/S
20.76
EV/EBIT
74.93
EV/EBITDA
66.75
EV/Sales
20.92
IDXX's price to earnings (P/E) is 57% higher than its 5-year quarterly average of 56.1 and 33% higher than its last 4 quarters average of 66.0
The company's EPS has surged by 55% YoY and by 16% QoQ
The company's equity rose by 11% QoQ
The price to book (P/B) is 10% more than the last 4 quarters average of 76.4
The P/S is 123% above the 5-year quarterly average of 9.3 and 52% above the last 4 quarters average of 13.7
IDXX's revenue is up by 16% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has shrunk by 50% YoY and by 18% QoQ
The return on assets rose by 28% year-on-year and by 10% since the previous quarter
Idexx Laboratories's return on invested capital has increased by 24% YoY and by 13% QoQ
The company's return on sales rose by 21% YoY and by 9% QoQ

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 43% higher than its total liabilities
The quick ratio has soared by 162% YoY but it has decreased by 4.1% QoQ
IDXX's current ratio has surged by 108% year-on-year but it is down by 2.7% since the previous quarter
The debt is 40% more than the equity
IDXX's debt to equity has shrunk by 88% YoY and by 10% QoQ
The debt has contracted by 21% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.